Aeromedical Isolation Team

The Aeromedical Isolation Team (AIT), also known as SMART-AIT, was established in 1978 by the US Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick, Maryland. Its creation was a strategic response to the growing global threat of highly contagious and potentially weaponized infectious diseases. The AIT was designed as a premier rapid-response unit with worldwide airlift capability, specifically tasked with the safe evacuation and management of patients under Biosafety Level 4 (BSL-4) conditions.

This level of containment is reserved for the most dangerous biological agents that pose an extreme risk of life-threatening disease. The AIT's existence underscored a critical need for a specialized military asset capable of projecting medical containment capabilities across vast distances, ensuring that no location was too remote or too dangerous for effective patient retrieval and care.

The AIT's operational effectiveness was built upon a foundation of cutting-edge technology and relentless training. A key component was its integrated portable containment laboratory, which allowed for on-site diagnostics and management. For patient transport, the team utilized state-of-the-art transit isolators.

These were sophisticated, self-contained units designed to provide a completely sealed environment, preventing any exchange of air or biological material between the patient and the outside world. This ensured maximum bio-containment during flight. The AIT was part of MEDCOM’s Special Medical Augmentation Response Teams (SMART teams), signifying its role as a specialized augmentation asset.

Continuous training and drills were paramount, preparing the team for diverse contingency missions, including complex bioterrorism scenarios and the extraction of researchers from remote, high-risk environments.

Throughout its operational lifespan, the AIT maintained a constant state of readiness, often being placed on alert status. However, the extreme nature of their mission meant that actual "real world" deployments were infrequent, occurring only four times. These limited deployments underscore the effectiveness of global disease surveillance and the rarity of situations requiring such a high level of specialized intervention.

The missions were invariably high-stakes, involving the retrieval of individuals infected with exotic pathogens from challenging international locations or responding to potential bioterrorism events. The strategic importance of these deployments lay in their ability to contain potential outbreaks at their source and prevent the international spread of dangerous diseases, safeguarding global public health.

In 2010, the Aeromedical Isolation Team was decommissioned, marking the end of an era for this unique military medical capability. Its mission, however, was not abandoned but rather transitioned to the US Air Force's Critical Care Air Transport Teams (CCATTs), who integrated similar high-containment protocols into their operations. The AIT's legacy is significant; it pioneered and refined the complex logistical and medical procedures required for aeromedical evacuation of patients with highly infectious diseases.

Their work established critical precedents for bio-containment in air transport, influencing the development of subsequent specialized medical evacuation units and protocols. The AIT demonstrated the feasibility and necessity of dedicated rapid-response teams for global health security in an increasingly interconnected world.